Given that BA has previously been implicated in blocking diverse canonical YY1/FAS [27], ERβ [28], insulin/IGF‐1 [29], MAPK/ERK [30] and Notch [31] signalling pathways in different pathological models, we next investigated which pathway was responsible for UBE2T downregulation in glioma. The gene discussed is INS; the disease is central nervous system cancer.